Aprecitentan (Tryvio) side effects and what to do about them

As an innovative new antihypertensive drug, while Aprocitentan-Tryvio exerts its therapeutic effect on hypertension, it also needs to pay attention to potential side effects. Like other endothelin receptor antagonists, it may induce adverse reactions related to vasodilation, such as mild headache, dizziness, hypotension, etc. Most of these manifestations are related to the rate of blood pressure drop. Once the patient adapts to the drug, the symptoms tend to gradually alleviate. For clinical use, doctors will adjust the starting dose and medication rhythm according to individual conditions to reduce early discomfort.

Aprecitentan may have some effects on liver function, a common feature of endothelin pathway antagonists. Therefore, during the treatment process, regular monitoring of liver function indicators is a necessary measure. Once significant transaminase elevation or jaundice is found, it should be promptly evaluated whether the drug needs to be adjusted or discontinued. In addition, some patients may develop mild edema, especially in the lower extremities, which is related to vasodilation and fluid redistribution. Most of these symptoms can be improved through dose reduction, diuretics or lifestyle intervention.

It should be noted that the metabolic pathway of aprecitentan involves liver enzyme systems and may interact with some common drugs. Therefore, doctors will ask patients in detail about their past medication history when prescribing to avoid increasing the risk of side effects due to drug interactions. In practical applications, it is recommended that patients strictly follow medical instructions and not increase or decrease the dosage on their own or use it in combination with other drugs.

In terms of strategies for dealing with side effects, clinicians place more emphasis on monitoring and individualized adjustments. For example, if a patient is significantly dizzy due to hypotension, he or she should reduce excessive position changes and consider adjusting the drug dose if necessary. For mild edema, it can be improved by reducing salt intake and increasing daily exercise. Liver function monitoring needs to be combined with blood test results, and medication discontinuation and observation should be adopted when necessary to ensure overall safety.

Reference materials:https://go.drugbank.com/drugs/DB15059